Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280085 · ClinicalTrials.gov registry record · NA
The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.
A NA study, sponsored by Pfizer.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00280085 is a NA study that was terminated before completion, run by Pfizer. The registered enrollment target is 29 participants.
The verdict
NCT00280085, a NA study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Assess pancreatic beta cell function using MR imaging.
Interventions
- DRUG Arginine
- PROCEDURE MR imaging
- PROCEDURE Glucose clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00280085
The ClinicalTrials.gov registry entry for NCT00280085 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arginine is the first listed.
NCT00280085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00280085 about?
NCT00280085 is a clinical study titled "The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.". Assess pancreatic beta cell function using MR imaging.
What is the current status of trial NCT00280085?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2005-12. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00280085?
The interventions under investigation include: Arginine (DRUG), MR imaging (PROCEDURE), Glucose clamp (PROCEDURE).
Who is sponsoring clinical trial NCT00280085?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.